Markets:

Overview

News

Currencies

International

Treasuries

Atai Beckley N.V - Common Shares (NQ:ATAI)

3.800 +0.140 (+3.83%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Atai Beckley N.V - Common Shares

< Previous 1 2

...

13 14 15 16 17 18 19 20 21

...

29 30 Next >

atai Life Sciences Announces Positive Initial Results for Phase 1 Trial of KUR-101, an Oral Formulation of Mitragynine for OUD

October 12, 2022

From atai Life Sciences

Via GlobeNewswire

Numinus Wellness, Small Pharma Among Top Psychedelic Movers Of Today ↗

October 11, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 7.61% at $0.12

Via Benzinga

Psychedelic Drugs Prove Their Worth In Clinical Trials

October 11, 2022

Novel psychedelic drugs have continuously proven their worth in clinical trials. Just recently, one company revealed that it was in the process of finalizing its Phase 1 first-in-human clinical trial...

Via PressReach

Psychedelic Stock Gainers And Losers From October 10, 2022 ↗

October 10, 2022

GAINERS: Cybin (AMEX:CYBN) shares closed up 5.51% at $0.63 LOSERS:

Via Benzinga

Psychedelic Drug Stocks Index Up Slightly This Week ↗

October 08, 2022

There are 8 stocks in the munKNEE Psychedelic Drug Stocks Index and this article reveals how its constituents performed this week, in descending order, since the end of August and YTD.

Via Talk Markets

Psyched: CA's Psychedelic-Assisted Treatments, Ketamine Therapy, Near-Death Experience And More ↗

October 07, 2022

Alberta Becomes The First Canadian Province To Regulate Psychedelics-Assisted Therapy

Via Benzinga

Psychedelic Stock Gainers And Losers From October 6, 2022 ↗

October 06, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 45.41% at $0.22

Via Benzinga

Colorado to Vote on Legalizing Psychoactives in November

October 05, 2022

Voters in Colorado will have a say in the legalization of psychedelic drugs this November as an initiative to legalize psilocybin mushrooms and other naturally occurring psychedelics appears on the...

Via PressReach

Topics Supply Chain

Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease

October 05, 2022

A Toronto-based biotech firm is developing a new psychedelic medicine to cure Alzheimer’s disease, announcing recently that it has gotten approval from Argentina’s regulators to begin a Phase ll...

Via PressReach

Topics Cannabis

Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease

October 05, 2022

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – October 5, 2022 – A Toronto-based biotech firm is developing a new psychedelic medicine to cure Alzheimer’s disease,...

Via FinancialNewsMedia

Topics Cannabis

atai's Phase 1 Synthetic DMT-Based Drug Clinical Trial Begins Patient Dosing ↗

October 05, 2022

Clinical-stage biopharma company atai Life Sciences N.V. (NASDAQ: ATAI) has commenced dosing volunteers for its ongoing Phase 1 clinical study investigating its proprietary DMT-based VLS-01 for...

Via Benzinga

atai Life Sciences Announces First Subject Dosed in Phase 1 Trial of Buccal and IV VLS-01, a Synthetic Form of DMT

October 05, 2022

From atai Life Sciences

Via GlobeNewswire

Allied, GH Research Among Top Psychedelic Movers Of Today ↗

October 04, 2022

GAINERS: Allied (OTC:ALID) shares closed up 31.58% at $0.60

Via Benzinga

atai Life Sciences to Participate in October Investor Events & Host Virtual R&D Day

October 04, 2022

From atai Life Sciences

Via GlobeNewswire

Cybin, GH Research Among Top Psychedelic Movers Of Today ↗

October 03, 2022

GAINERS: Cybin (AMEX:CYBN) shares closed up 20.50% at $0.58

Via Benzinga

September Cannabis Category Performances Ranged From -6.3% To -39.0% ↗

October 03, 2022

The performances of the 5 cannabis categories ranged from -6.3% to -39.0% in September, and are now -13.6% to -67.0%, YTD, depending on the category. The S&P 500, in comparison, was -8.6% in September...

Via Talk Markets

Major Psychedelic Stocks Continued To Decline In September ↗

October 02, 2022

There are 8 stocks in the munKNEE Psychedelic Compounds-Based Drug Stocks Index. Most - but interestingly not all - were down for the week and/or the month.

Via Talk Markets

Allied, Revive Therapeutics Among Top Psychedelic Movers Of Today ↗

September 30, 2022

GAINERS: Cybin (AMEX:CYBN) shares closed up 2.08% at $0.49

Via Benzinga

Psyched: Autopsy Reveals Death By Ketamine, LSD-Like Drugs Without Hallucinations, DEA & Right To Try Psilocybin ↗

September 30, 2022

Amended Autopsy Confirms Elijah McClain Died From Ketamine Injected By Paramedics Called By Cops

Via Benzinga

Allied, Compass Pathways Among Top Psychedelic Movers Of Today ↗

September 29, 2022

GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 6.17% at $3.44

Via Benzinga

Psychedelic Stock Gainers And Losers From September 28, 2022 ↗

September 28, 2022

GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 10.48% at $1.16

Via Benzinga

Biomind Labs, Allied Among Top Psychedelic Movers Of Today ↗

September 27, 2022

GAINERS: Biomind Labs (OTC:BMNDF) shares closed up 11.10% at $1.10

Via Benzinga

Atai's New MDMA-Based EMP-01 Compound Moves Forward To The Clinical Stage ↗

September 27, 2022

Atai Life Sciences' (NASDAQ: ATAI) wholly-owned subsidiary EmpathBio has received Medsafe central regulatory and the Health and Disability Ethics Committees (HDEC) approvals to begin participant...

Via Benzinga

Small Pharma, Revive Therapeutics Among Top Psychedelic Movers Of Today ↗

September 26, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 9.91% at $0.13

Via Benzinga

Psychedelic Stocks Continue To Plummet: -16% This Week; -33% MTD; Now -57% YTD ↗

September 25, 2022

Look at how the only psychedelic stocks with market caps larger than $50M gave performed this last week.

Via Talk Markets

Psychedelic Stock Gainers And Losers From September 22, 2022 ↗

September 22, 2022

GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 2.80% at $1.10

Via Benzinga

Atlanta Becomes Latest City to Consider Decriminalizing Psychedelics

September 22, 2022

Atlanta just became the latest city to consider decriminalizing psychedelics. On September 12, just one week after San Francisco officially decriminalized psychedelics, a meeting was held by the City...

Via PressReach

Atlanta Becomes Latest City to Consider Decriminalizing Psychedelics

September 22, 2022

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 22, 2022 – Atlanta just became the latest city to consider decriminalizing psychedelics. On September 12, just one...

Via FinancialNewsMedia

Psychedelic Stock Gainers And Losers From September 21, 2022 ↗

September 21, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 7.87% at $0.32

Via Benzinga

Seelos Therapeutics, Allied Among Top Psychedelic Movers Of Today ↗

September 20, 2022

GAINERS: Allied (OTC:ALID) shares closed up 7.83% at $0.62

Via Benzinga

< Previous 1 2

...

13 14 15 16 17 18 19 20 21

...

29 30 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Atai Beckley N.V - Common Shares (NQ:ATAI)

All News about Atai Beckley N.V - Common Shares

Starting at $3.75/week.

Subscribe Today